Introduction. After radiotherapy (XRT) for head and neck tumors, xerostomia
is observed as a chronic side effect. We investigated whether the topical
use of a mucin-containing spray can help patients to cope with this problem
.
Patients and methods. A total of 73 patients with xerostomia post XRT recei
ved a bottle of the mucin spray (Saliva medac) and a questionnaire, 59 of w
hich were compete and returned.
Results. Ali patients had received some form of prior treatment, which had
been applied 16 times/day on average (median: 15 times/day). The mucin spra
y had to be used less frequently, i.e., 11 times/day (median: 5 times/day),
(p <0,001,Wilcoxon's rank test). Additionally, they reported being able to
sleep significantly better when using the mucin spray (2.9 vs 3.9 in the G
erman school grading system: 1=very good, 6=poor; p <0.001,Wilcoxon's rank
test). The spray was well accepted by the patients.
Conclusions. The spray was useful against xerostomia in irradiated patients
.